Lenalidomide for Patients With Myelofibrosis (MF)

clinical trial

Lenalidomide for Patients With Myelofibrosis (MF) is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00352794

P6099clinical trial phasephase II clinical trialQ42824440
P17countryUnited States of AmericaQ30
P582end time2018-03-08
P1050medical conditionchronic idiopathic myelofibrosisQ3857106
P2899minimum age18
P1132number of participants40
P4844research interventionprednisoneQ424972
(RS)-lenalidomideQ425681
P6153research siteThe University of Texas MD Anderson Cancer CenterQ1525831
P580start time2006-07-07
P8363study typeinterventional studyQ78089383
P1476titleEvaluation of Lenalidomide (CC-5013) and Prednisone as a Therapy for Patients With Myelofibrosis (MF)

Search more.